semaglutide menstruation and metformin improve menstrual cyclicity in overweight/obese women with polycystic ovary syndrome: a randomized semaglutide and menstrual changes Metabolic

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, a medication originally used to treat type 2 diabetes

2022;27:e13211

Causes of Cellulite Genetics Many patients develop cellulite because of genetics

Preclinical research indicates that GIPR activation also modulates lipid metabolism in adipose tissue and contributes to weight reduction through mechanisms distinct from GLP-1R pathways

Observational studies can identify patterns in real-world clinical data but they cannot fully exclude other confounding differences between patient groups which may explain the results

Similar content being viewed by others Log in or create a free account to read this content Gain free access to this article, as well as selected content from this journal and more on nature.com or References Piccinelli M, Wilkinson G